Clinical trial
Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
NCT00004993 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00004993 |
|---|---|
| Title | Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis |
| Official title | Can PTH Reverse Glucocorticoid-induced Osteoporosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Parathyroid hormone (hPTH 1-34) |
| Start date | Aug 1, 1999 |
| Completion | Aug 1, 2001 |
| First posted | Mar 20, 2000 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: